FDA Approves the Cleveland Cord Blood Center’s CLEVECORD™ for Stem Cell Transplants – PR Newswire (press release)
|
FDA Approves the Cleveland Cord Blood Center's CLEVECORD™ for Stem Cell Transplants
PR Newswire (press release) CLEVELAND, Sept. 12, 2016 /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration (FDA) has issued a biologics license to the Cleveland Cord Blood Center (CCBC) for CLEVECORD™, a stem cell product (HPC, Cord Blood) derived from … |
